An analytical method for detecting impurities including nitrosamines in salbutamol hydrochloride

By employing a liquid chromatography method with a specific mobile phase and gradient elution procedure, the problem of detecting multiple nitrosamine impurities in levosalbutanol hydrochloride was solved, achieving efficient and accurate impurity separation and detection, and improving detection efficiency and sensitivity.

CN118191132BActive Publication Date: 2024-11-08SHANDONG TAIHE PHARM TECH CO LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410267335.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-03-08
Publication Date
2024-11-08
Estimated Expiration
2044-03-08

AI Technical Summary

Technical Problem

Existing technologies are insufficient for the simultaneous and efficient detection of multiple nitrosamine impurities in levosalbutanol hydrochloride, resulting in low analytical detection efficiency.

Method used

An octadecylsilane-bonded silica gel column was used, with mobile phase A being a phosphoric acid solution and mobile phase B being an aqueous solution containing methanol, acetonitrile, and phosphoric acid. Combined with a specific gradient elution program and detection conditions, the separation and detection of various impurities were achieved.

Benefits of technology

It achieves good separation and accurate detection of multiple impurities in levosalbutanol hydrochloride, with simple operation, high specificity, high detection sensitivity, and reduced detection cost.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118191132B_ABST
    Figure CN118191132B_ABST
Patent Text Reader

Abstract

The invention discloses an analytical method for detecting impurities including nitrosamines in salbutamol hydrochloride, using an octadecylsilane bonded silica gel chromatographic column, the mobile phase including mobile phase A and mobile phase B, mobile phase A is a phosphoric acid solution, and mobile phase B is an aqueous solution containing methanol, acetonitrile, and phosphoric acid at the same time. The method of the invention realizes the separation and detection of 10 impurities including salbutamol impurities A, B, C, D, E, F, H, M, P, and Q; the method is simple to operate, has strong specificity, high detection sensitivity and accuracy, good linearity, and can accurately determine impurities such as potential genotoxicity of nitrosamines in salbutamol hydrochloride, which not only overcomes the technical barriers of currently commonly used gas quality or liquid quality detection of nitrosamine impurities, but also reduces the detection cost, and is an innovative method for improving and innovating the process of salbutamol hydrochloride raw materials and preparations and establishing and improving quality standards.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of drug analysis, and particularly relates to an analytical method for detecting impurities including nitrosamines in salbutamol hydrochloride. Background Art

[0002] Nitrosamine impurities are a class of highly active mutagenic impurities. They are classified as Class 2A carcinogens by the International Agency for Research on Cancer and are also included in the "concern queue" substances mentioned in the International Conference on Harmonization (ICH) guidance document M7 (R1). The U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA) and the National Medical Products Administration (NMPA) have successively issued documents related to nitrosamine impurities. Research on nitrosamine impurities has become one of the keys to ensuring product quality. According to the guidelines for the allowable intake of drug-based nitrosamine impurities (NDSRI) published by the FDA, the allowable intake of salbutamol nitrosamide is 1500ng / day. At present, there are no reports of salbutamol nitrosamide impurities in the United States Pharmacopoeia (USP) and other literature and patents.

[0003] In addition, there are other impurities in the salbutamol hydrochloride raw material, as shown in the following table:

[0004]

[0005]

[0006] The nitrosamine impurity is impurity Q in the table.

[0007] If these impurities can be detected at the same time, the efficiency of analytical testing will be greatly improved. Summary of the invention

[0008] In order to solve the deficiencies of the prior art, the present invention provides an analytical method for detecting impurities including nitrosamines in salbutamol hydrochloride, which can simultaneously separate and detect 10 impurities A, B, C, D, E, F, H, M, P, and Q in salbutamol hydrochloride. The technical solution of the present invention is as follows:

[0009] The invention discloses an analytical method for detecting impurities including nitrosamines in levosalbutamol hydrochloride, which adopts an octadecylsilane bonded silica gel chromatographic column, wherein the mobile phase comprises a mobile phase A and a mobile phase B, wherein the mobile phase A is a phosphoric acid solution, and the mobile phase B is an aqueous solution simultaneously containing methanol, acetonitrile and phosphoric acid.

[0010] Preferably, the chromatographic column uses an Agilent InfinityLab Poroshell 120EC-C18 column.

[0011] Preferably, the mobile phase A is a phosphoric acid solution with a mass fraction of 0.05% to 0.15%, preferably a 0.1% phosphoric acid solution.

[0012] Preferably, the volume ratio of water-methanol-acetonitrile-phosphoric acid in the mobile phase B is 28:36:36:0.1 to 32:34:34:0.1, preferably 30:35:35:0.1.

[0013] Preferably, the mobile phase gradient elution program is: within 0 to 40 minutes, the volume ratio of mobile phase A and mobile phase B linearly changes from 90 to 100:0 to 10 to 70:30; within 40 to 50 minutes, the volume ratio of mobile phase A and mobile phase B linearly changes from 70:30 to 28:72; within 50 to 51 minutes, the volume ratio of mobile phase A and mobile phase B remains linearly changed from 28:72 to 0:100; within 51 to 56 minutes, the volume ratio of mobile phase A and mobile phase B remains unchanged at 0:100; within 56 to 57 minutes, the volume ratio of mobile phase A and mobile phase B linearly changes from 0:100 to 90 to 100:0 to 10; within 57 to 70 minutes, the volume ratio of mobile phase A and mobile phase B remains unchanged at 90 to 100:0 to 10.

[0014] Preferably, the flow rate of the mobile phase is 0.8 to 1.2 ml / min, preferably 1.0 ml / min.

[0015] Preferably, the column temperature of the chromatographic column is 30°C to 40°C, preferably 35°C.

[0016] The analytical method also includes sample preparation:

[0017] Test solution: Take the sample and dissolve it in solvent to prepare a solution with a concentration of 0.5 mg / ml. The solvent is water;

[0018] Reference solution: Take the salbutamol hydrochloride reference substance, dissolve it in a solvent and prepare a solution with a concentration of 0.4 μg / ml;

[0019] Accurately measure the test solution and reference solution, inject them into the liquid chromatograph respectively, and record the chromatogram.

[0020] In the test solution of levosalbutamol hydrochloride, the relative retention times of impurities P, M, A, H, B, C, D, E, Q, and F are 0.97, 1.08, 1.15, 1.24, 1.51, 1.54, 1.66, 1.97, 2.54, and 2.70, respectively.

[0021] The analytical method also includes the calculation of impurity content:

[0022] If there are impurity peaks in the chromatogram of the test solution, calculate the content of each impurity by the external standard method of the main component reference substance with the correction factor added;

[0023] The correction factors of impurities P, M, A, H, B, C, D, E, Q, and F are 1.1, 0.7, 1.1, 1.0, 0.8, 0.9, 0.3, 1.0, 0.7, and 0.7, respectively. Among them, impurities P, A, H, C, and E do not need to be corrected.

[0024] Compared with the prior art, the present invention has the following beneficial effects:

[0025] 1. The method of the present invention achieves good separation and accurate detection of 10 impurities including A, B, C, D, E, F, H, M, P, and Q of salbutamol;

[0026] 2. The method of the present invention is simple to operate, has strong specificity, high detection sensitivity and accuracy, good linearity, and can accurately determine the potential genotoxic impurities such as nitrosamines in salbutamol hydrochloride. It not only overcomes the technical barriers of the currently commonly used gas-gas or liquid-gas detection of nitrosamine impurities, but also reduces the detection cost. It is an innovative method for improving and innovating the process of salbutamol hydrochloride raw materials and preparations and establishing and improving quality standards. BRIEF DESCRIPTION OF THE DRAWINGS

[0027] The accompanying drawings in the specification, which constitute a part of the present invention, are used to provide a further understanding of the present invention. The exemplary embodiments of the present invention and their descriptions are used to explain the present invention and do not constitute improper limitations on the present invention.

[0028] Figure 1 This is the specificity test chromatogram in the methodological validation test of Example 2;

[0029] Figure 2 Summary of the durability test results in the methodology verification test of Example 2;

[0030] Figure 3 This is the chromatogram of the comparative example 1.1 test when the mobile phase B is acetonitrile;

[0031] Figure 4 This is the chromatogram when the mobile phase of the comparative example 1.2 test contains a phosphate solution;

[0032] Figure 5 This is the chromatogram when the mobile phase B of the comparative example 1.3 experiment is water-acetonitrile-phosphoric acid (30:70:0.1);

[0033] Figure 6 This is the chromatogram when the mobile phase B of the comparative example 1.4 experiment is water-methanol-acetonitrile-phosphoric acid (30:25:45:0.1);

[0034] Figure 7This is the chromatogram of the comparative example 1.5 test when the mobile phase B is methanol;

[0035] Figure 8 This is the chromatogram when the mobile phase B of the comparative example 1.6 experiment is water-methanol-acetonitrile (30:35:35);

[0036] Fig. 9 This is the chromatogram when the trapping column is not used in the test of Comparative Example 1.7;

[0037] Fig.10 This is the chromatogram of the comparative example 2.1 test when the mobile phase B is methanol;

[0038] Fig.11 This is the chromatogram of the comparative example 2.1 test when the mobile phase B is acetonitrile;

[0039] Fig.12 This is the chromatogram of the comparative example 2.2 test using Kromasil 100-5-C8 chromatographic column;

[0040] Fig.13 This is the chromatogram of Comparative Example 2.3 when the GL Sciences Inertsil ODS-3 chromatographic column was used. DETAILED DESCRIPTION

[0041] It should be noted that the following detailed descriptions are exemplary and are intended to provide further explanation of the present invention. Unless otherwise specified, all technical and scientific terms used herein have the same meanings as those commonly understood by those skilled in the art to which the present invention belongs.

[0042] It should be noted that the terms used herein are only for describing specific embodiments and are not intended to limit exemplary embodiments according to the present invention. As used herein, unless the context clearly indicates otherwise, the singular form is also intended to include the plural form. In addition, it should be understood that when the terms "comprising" and / or "including" are used in this specification, it indicates the presence of features, steps, operations, devices, components and / or combinations thereof.

[0043] Example 1, an analytical method for detecting impurities including nitrosamines in salbutamol hydrochloride

[0044] (1) Testing conditions

[0045] Instrument: Waters Acquity Arc high performance liquid chromatograph;

[0046] Detection wavelength: 220nm;

[0047] Chromatographic column: Agilent InfinityLab Poroshell 120EC-C18 octadecylsilane bonded silica gel column (4.6 mm × 250 mm, 4 μm);

[0048] Solvent: water;

[0049] Mobile phase A: 0.1% phosphoric acid solution;

[0050] Mobile phase B: water-methanol-acetonitrile-phosphoric acid (30:35:35:0.1);

[0051] Gradient elution program: within 0-40 minutes, the volume ratio of mobile phase A and mobile phase B linearly changes from 100:0 to 70:30; within 40-50 minutes, the volume ratio of mobile phase A and mobile phase B linearly changes from 70:30 to 28:72; within 50-51 minutes, the volume ratio of mobile phase A and mobile phase B linearly changes from 28:72 to 0:100; within 51-56 minutes, the volume ratio of mobile phase A and mobile phase B remains unchanged at 0:100; within 56-57 minutes, the volume ratio of mobile phase A and mobile phase B linearly changes from 0:100 to 100:0; within 57-70 minutes, the volume ratio of mobile phase A and mobile phase B remains unchanged at 100:0.

[0052] Flow rate: 1.0 mL / min;

[0053] Column temperature: 35°C;

[0054] Injection volume: 10 μL.

[0055] (2) Detection steps

[0056] Test solution: Take the sample and dissolve it in solvent to prepare a solution with a concentration of 0.5 mg / ml. The solvent is water;

[0057] Reference solution: Take the salbutamol hydrochloride reference substance, dissolve it in a solvent and prepare a solution with a concentration of 0.5 μg / ml;

[0058] System suitability solution: Take appropriate amounts of levosalbutamol hydrochloride reference substance, impurity B reference substance, impurity C reference substance and impurity F reference substance, add mobile phase A to dissolve and dilute to make a mixed solution containing approximately 0.5 mg of levosalbutamol hydrochloride, 0.5 μg of impurity B, 0.75 μg of impurity C and 0.5 μg of impurity F per 1 ml.

[0059] Accurately measure the system suitability solution, test solution and reference solution, inject them into the liquid chromatograph respectively, and record the chromatogram. In the chromatogram of the system suitability solution, the peaks appear in the order of levosalbutamol, impurity B, impurity C and impurity F, and the separation between the impurity B peak and the impurity C peak should be greater than 1.5.

[0060] Example 2, verification test

[0061] In order to verify the specificity and accuracy of the detection method designed in this technical solution, methodological validation tests including specificity test, quantitative limit and detection limit test, linearity and range test, stability test, precision test, accuracy test and durability test were carried out. The test process and results are described as follows:

[0062] 2.1, Specificity test

[0063] Preparation of impurity reference stock solution: Take about 2.5 mg of impurity A, B, C, D, E, F, H, M, and P reference substances, place them in 50 ml volumetric flasks respectively, add solvent to dissolve and dilute to the scale, and shake well.

[0064] Impurity Q reference stock solution: Take about 2 mg of impurity Q, weigh accurately, dissolve in acetonitrile and quantitatively dilute to make a solution containing 2 μg of impurity Q per 1 ml.

[0065] Impurity reference substance mixed stock solution ①: Accurately measure 2 ml of impurity A, B, C, D, E, H, M, P reference substance stock solution and 3 ml of impurity F reference substance stock solution, place them in the same 25 ml volumetric flask, dilute to the scale with solvent, and shake well.

[0066] Impurity reference solution: Accurately measure 2.5 ml of impurity reference mixed stock solution ① and 1 ml of impurity Q reference stock solution, place in a 10 ml volumetric flask, dilute to the scale with solvent, and shake well.

[0067] Test solution: Take about 10 mg of sample, weigh accurately, place in a 20 ml volumetric flask, add solvent to dissolve and dilute to the scale, shake well.

[0068] Mixed solution: Take about 10 mg of sample, weigh accurately, measure 5 ml of impurity reference mixed stock solution ① and 2 ml of impurity Q reference stock solution, put them in the same 20 ml volumetric flask, add solvent to dissolve and dilute to the scale, and shake well.

[0069] Preparation of impurity localization solution: Accurately measure 0.2 ml of each impurity A, B, C, D, E, F, H, M, and P reference substance stock solution, place them in 10 ml volumetric flasks, dilute to the scale with solvent, and shake well.

[0070] Impurity Q positioning solution: Accurately measure 1 ml of the impurity Q reference stock solution, place it in a 10 ml volumetric flask, dilute to the scale with solvent, and shake well.

[0071] Accurately measure the solvent, reference solution, each impurity location solution, test solution and mixed solution, inject them into the liquid chromatograph respectively, and record the chromatogram, such as Figure 1The relative retention times of impurities A, B, C, D, E, F, H, M, P, and Q are 1.15, 1.51, 1.54, 1.66, 1.97, 2.70, 1.24, 1.08, 0.97, and 2.54, respectively.

[0072] The experimental results show that the solvent does not interfere with the detection of impurities A, B, C, D, E, F, H, M, P and Q, and the peaks of each component are baseline separated; each impurity positioning solution is detected by a PDA detector, and the peak purity of each impurity peak meets the requirements, and this method has strong specificity.

[0073] 2.2 Linearity and range tests

[0074] Stock solution of salbutamol hydrochloride reference substance: Take about 2.5 mg of salbutamol hydrochloride reference substance, accurately weigh it, put it in a 20 ml volumetric flask, add solvent to dissolve and dilute to the scale, and shake well.

[0075] Preparation of impurity reference stock solution: Take about 2.5 mg of impurity A, B, C, D, E, F, H, M, and P reference substances, place them in 20 ml volumetric flasks respectively, add solvent to dissolve and dilute to the scale, and shake well.

[0076] Impurity reference substance mixed stock solution ①: Accurately measure 2 ml each of salbutamol hydrochloride reference substance stock solution, impurity A, B, E, F, M, P reference substance stock solutions, 3 ml each of impurity C and H reference substance stock solutions, and 1 ml of impurity D reference substance stock solution, place them in the same 50 ml volumetric flask, dilute to the scale with solvent, and shake well.

[0077] Impurity reference substance mixed stock solution ②: Accurately measure 2 ml of salbutamol hydrochloride reference substance stock solution, impurity A, B, C, D, E, F, H, M and P reference substance stock solutions respectively, place them in the same 25 ml volumetric flask, dilute to the scale with solvent, and shake well.

[0078] Impurity reference substance mixed stock solution ③: Accurately measure 3 ml each of salbutamol hydrochloride reference substance stock solution, impurity A, B, C, E, F, H, M and P reference substance stock solutions, and 1 ml of impurity D reference substance stock solution, place them in the same 50 ml volumetric flask, dilute to the scale with solvent, and shake well.

[0079] Impurity reference substance mixed stock solution ④: Accurately measure 2 ml of salbutamol hydrochloride reference substance stock solution and impurity F reference substance stock solution respectively, place them in the same 25 ml volumetric flask, dilute to the scale with solvent, and shake well.

[0080] Linear solution ①: Accurately measure 1 ml of the impurity reference mixed stock solution ①, place it in a 20 ml volumetric flask, dilute to the scale with solvent, and shake well.

[0081] Linear solution ②: Accurately measure 1 ml of the impurity reference mixed stock solution ②, place it in a 20 ml volumetric flask, dilute to the scale with solvent, and shake well.

[0082] Linear solution ③: Accurately measure 2 ml of impurity reference mixed stock solution ③, place in a 20 ml volumetric flask, dilute to the scale with solvent, and shake well.

[0083] Linear solution ④: Accurately measure 2 ml of impurity reference mixed stock solution ②, place in a 20 ml volumetric flask, dilute to the scale with solvent, and shake well.

[0084] Linear solution ⑤: Accurately measure 3 ml of the impurity reference mixed stock solution ②, place it in a 20 ml volumetric flask, dilute to the scale with solvent, and shake well.

[0085] Linear solution ⑥: Accurately measure 4 ml of the impurity reference mixed stock solution ②, place it in a 20 ml volumetric flask, dilute to the scale with solvent, and shake well.

[0086] Linear solution ⑦: Accurately measure 6 ml of the impurity reference mixed stock solution ④, place it in a 20 ml volumetric flask, dilute to the scale with solvent, and shake well.

[0087] Impurity Q reference substance stock solution: Take about 2 mg of impurity Q reference substance, accurately weigh it, place it in a 20 ml volumetric flask, add acetonitrile to dissolve and dilute to the scale, and shake well.

[0088] Stock solution of salbutamol hydrochloride reference substance: Take about 2 mg of salbutamol hydrochloride reference substance, accurately weigh it, place it in a 20 ml volumetric flask, add water to dissolve and dilute to the scale, and shake well.

[0089] Reference substance stock solution: Accurately measure 1 ml each of impurity Q reference substance stock solution and salbutamol hydrochloride reference substance stock solution, place in a 50 ml volumetric flask, dilute to the scale with acetonitrile, and shake well.

[0090] Linear solution: Accurately measure 1 ml, 1 ml, 2 ml, 2 ml, 3 ml, 2 ml and 5 ml of the reference stock solution and place them in 50 ml, 20 ml, 25 ml, 20 ml, 20 ml, 10 ml and 20 ml volumetric flasks respectively. Dilute to the scale with water and shake well. Use them as 20%, 50%, 80%, 100%, 150%, 200% and 250% linear solutions respectively.

[0091] Take each impurity reference substance and salbutamol hydrochloride reference substance and quantitatively dilute them with solvent to prepare solutions with signal-to-noise ratio of each component peak height of about 10, which are used as quantitative limit solutions, and the quantitative limit solution is taken as the first linear point.

[0092] Accurately measure 10 μl of each linear solution and inject it into the high performance liquid chromatograph to record the chromatogram. Perform linear regression with the concentration C (μg / ml) of each component as the horizontal axis and the peak area A of each component as the vertical axis. The test results are shown in Table 1.

[0093] Table 1 Linearity and range test data

[0094]

[0095]

[0096] The test results show that the components have a good linear relationship.

[0097] 2.3. Limit of Quantitation and Limit of Detection Test

[0098] Accurately measure the appropriate amount of reference stock solution under the "Linearity and Range Test" item, gradually add solvent and prepare a series of concentration solutions. Accurately measure this solution and inject it into the liquid chromatograph, record the chromatogram, the signal-to-noise ratio is about 10:1, as the quantitative limit solution; the signal-to-noise ratio is about 3:1, as the detection limit solution. The test results are shown in Tables 2 and 3.

[0099] Table 2 Quantitation limit and detection limit test data 1

[0100]

[0101] Table 3 Quantitation limit and detection limit test data 2

[0102]

[0103] It can be seen from the results that this method can detect or quantitatively detect various impurities at lower concentrations, and this method has high sensitivity.

[0104] 2.4 Stability test

[0105] Stock solution of salbutamol hydrochloride reference substance: Take about 2.5 mg of salbutamol hydrochloride reference substance, place it in a 20 ml volumetric flask, add solvent to dissolve and dilute to the scale, and shake well.

[0106] Stock solution of impurity reference substance: Take about 2.5 mg of impurity A, B, C, D, E, F, H, M, and P reference substances, place them in 20 ml volumetric flasks respectively, add solvent to dissolve and dilute to the scale, and shake well.

[0107] Impurity reference substance mixed stock solution ①: Accurately measure 4 ml of impurity A, B, C, D, E, H, M, P reference substance stock solution and 6 ml of impurity F reference substance stock solution, place them in the same 50 ml volumetric flask, dilute to the scale with solvent, and shake well.

[0108] Impurity reference solution: Accurately measure ①2 ml of the impurity reference mixed stock solution, place it in a 20 ml volumetric flask, dilute to the scale with solvent, and shake well.

[0109] Levosalbutamol hydrochloride reference solution: accurately measure 1 ml of levosalbutamol hydrochloride reference stock solution, place it in a 25 ml volumetric flask, dilute to the mark with solvent, shake well; accurately measure 2 ml, place it in a 10 ml volumetric flask, dilute to the mark with solvent, shake well.

[0110] Impurity reference substance mixed stock solution ②: Accurately measure 2 ml of impurity A, B, E, F, M and P reference substance stock solution, 1 ml of impurity D reference substance stock solution, and 3 ml of impurity C and H reference substance stock solution, place them in the same 50 ml volumetric flask, dilute to the scale with solvent, and shake well.

[0111] Test solution: Take about 10 mg of sample, weigh accurately, place in a 20 ml volumetric flask, add solvent to dissolve and dilute to the scale, shake well.

[0112] Impurity Q reference substance stock solution: Take about 2 mg of the impurity Q reference substance, accurately weigh it, add acetonitrile to dissolve it and quantitatively dilute it to make a solution containing 2 μg of impurity Q per 1 ml.

[0113] Impurity Q reference solution: Accurately measure 2 ml of the impurity Q reference stock solution, place it in a 20 ml volumetric flask, dilute to the scale with water, and shake well.

[0114] The impurity reference solution, impurity Q reference solution, salbutamol hydrochloride reference solution and the test solution were placed at room temperature, and 10 μl was accurately measured at different time points, injected into the liquid chromatograph, and the chromatogram was recorded. The test results are shown in Tables 4 to 7.

[0115] Table 4 Levosalbutamol hydrochloride reference solution stability test results

[0116] Time / h 0 5 10 15 20 25 48 Peak area 14982 14083 14402 14308 14182 14159 14238 Ratio of peak area to 0 hour (%) — 94.0 96.1 95.5 94.7 94.5 95.0

[0117] Table 5 Impurity reference solution peak area stability test results

[0118] Time / h 0 5 10 15 20 25 48 Impurity P 12492 12574 12517 12630 12551 12476 12397 Impurity M 20155 20060 20131 20174 20030 20078 20093 Impurity A 14606 14633 14563 14516 14400 14474 14526 Impurity H 16253 16243 16184 16089 16075 15950 15961 Impurity B 19290 19646 19488 18891 19128 19406 19700 Impurity C 16693 16813 16682 16606 16649 16913 16870 Impurity D 47634 47751 47559 47619 47759 47523 48781 Impurity E 16834 16747 16640 16594 16543 16619 16561 Impurity Q 4564 4644 4543 4861 4799 4810 4320 Impurity F 33354 33301 33182 33358 33181 33306 34171

[0119] Table 6 Stability test results of the ratio of the impurity reference solution to the peak area at 0 hours (II)

[0120] Time / h 0 5 10 15 20 25 48 Impurity P(%) — 100.7 100.2 101.1 100.5 99.9 99.2 Impurity M(%) — 99.5 99.9 100.1 99.4 99.6 99.7 Impurity A(%) — 100.2 99.7 99.4 98.6 99.1 99.5 Impurity H(%) — 99.9 99.6 99.0 98.9 98.1 98.2 Impurity B(%) — 101.8 101.0 97.9 99.2 100.6 102.1 Impurity C(%) — 100.7 99.9 99.5 99.7 101.3 101.1 Impurity D(%) — 100.2 99.8 100.0 100.3 99.8 102.4 Impurity E(%) — 99.5 98.8 98.6 98.3 98.7 98.4 Impurity Q(%) — 101.8 99.5 106.5 105.1 105.4 94.7 Impurity F(%) — 99.8 99.5 100.0 99.5 99.9 102.4

[0121] Table 7 Test solution stability test results

[0122] Time / h 0 5 10 15 20 25 48 Impurity P 0.02 0.02 0.02 0.02 0.02 0.02 0.01 Impurity M ND ND ND ND ND ND ND Impurity A 0.01 0.01 0.01 0.01 0.01 0.01 0.01 Impurity H ND ND ND ND ND ND ND Impurity B 0.01 0.01 0.01 0.01 0.01 0.01 0.01 Impurity C ND ND ND ND ND ND ND Impurity D 0.05 0.05 0.05 0.05 0.05 0.05 0.05 Impurity E ND ND ND ND ND ND ND Impurity Q ND ND ND ND ND ND ND Impurity F 0.01 0.01 0.01 0.01 0.01 0.01 0.01 Other single impurities 0.03 0.03 0.02 0.02 0.03 0.02 0.02 Total impurities 0.16 0.16 0.15 0.15 0.16 0.15 0.14

[0123] Note: ND stands for not detected.

[0124] According to the results, the impurity reference solution, salbutamol hydrochloride reference solution and impurity Q reference solution have good stability when placed at room temperature for 48 hours; after the test solution is prepared and placed at room temperature for 48 hours, the difference between the measured amount of each impurity and the 0h content is within the range of ±0.02%, and no degradation impurities that affect the detection of each impurity are produced in the chromatogram of the test solution. The test solution has good stability when placed at room temperature for 48 hours.

[0125] 2.5 Precision test

[0126] 1. Repeatability

[0127] Levosalbutamol hydrochloride reference solution: Take about 100 mg of levosalbutamol hydrochloride reference, dissolve it in a solvent and quantitatively dilute it to make a solution containing 0.5 μg of levosalbutamol hydrochloride per 1 ml.

[0128] Stock solution of impurity reference substance: Take about 2.5 mg of impurity A, B, C, D, E, F, H, M, and P reference substances and place them in 9 different 20 ml volumetric flasks respectively. Add solvent to dissolve and dilute to the scale and shake well.

[0129] Impurity reference substance mixed stock solution ①: Accurately measure 2 ml of impurity A, B, E, F, M and P reference substance stock solution, 1 ml of impurity D reference substance stock solution, and 3 ml of impurity C and H reference substance stock solution, place them in the same 50 ml volumetric flask, dilute to the scale with solvent, and shake well.

[0130] Test solution: Take about 10 mg of sample, weigh accurately, place in a 20 ml volumetric flask, add solvent to dissolve and dilute to the scale, shake well.

[0131] Spiked test solution①: Take about 10 mg of sample, weigh accurately, and accurately measure 2 ml of impurity reference mixed stock solution①, place in the same 20 ml volumetric flask, add solvent to dissolve and dilute to scale, shake well. Prepare 6 copies in parallel.

[0132] Impurity Q reference substance stock solution: Take about 2 mg of the impurity Q reference substance, accurately weigh it, add acetonitrile to dissolve it and quantitatively dilute it to make a solution containing 2 μg of impurity Q per 1 ml.

[0133] Levosalbutamol hydrochloride reference substance stock solution ②: Take about 2 mg of levosalbutamol hydrochloride reference substance, accurately weigh it, dissolve it in a solvent and quantitatively dilute it to make a solution containing 2 μg of levosalbutamol hydrochloride per 1 ml.

[0134] Reference substance solution ②: Accurately measure 2 ml each of impurity Q reference substance stock solution and salbutamol hydrochloride reference substance stock solution ②, place them in the same 20 ml volumetric flask, dilute to the scale with solvent, and shake well.

[0135] Spiked test solution ②: Take about 10 mg of sample, weigh accurately, and accurately measure 2 ml of impurity Q reference stock solution, place in the same 20 ml volumetric flask, add solvent to dissolve and dilute to scale, shake well. Prepare 6 copies in parallel.

[0136] Accurately measure the salbutamol hydrochloride reference solution, test solution, spiked test solution, reference solution ② and spiked test solution ②, inject them into the high performance liquid chromatograph respectively, and record the chromatogram. Calculate the content of each impurity by the main component reference external standard method with correction factor. The test results are shown in Table 8.

[0137] Table 8 Repeatability test results

[0138] Impurity content (%) 1 2 3 4 5 6 RSD(%) Impurity P 0.10 0.10 0.10 0.10 0.10 0.10 0 Impurity M 0.10 0.10 0.10 0.10 0.09 0.10 4.2 Impurity A 0.10 0.10 0.10 0.10 0.11 0.11 5.0 Impurity H 0.16 0.16 0.16 0.16 0.16 0.16 0 Impurity B 0.11 0.11 0.11 0.11 0.11 0.11 0 Impurity C 0.16 0.16 0.16 0.16 0.16 0.16 0 Impurity D 0.06 0.06 0.06 0.06 0.06 0.06 0 Impurity E 0.10 0.10 0.10 0.11 0.11 0.11 5.3 Impurity Q 0.04 0.04 0.04 0.04 0.04 0.04 0 Impurity F 0.11 0.11 0.11 0.11 0.11 0.11 0 Other single impurities 0.03 0.03 0.03 0.03 0.03 0.03 0 Total impurities 1.0 1.0 1.0 1.0 1.0 1.0 0

[0139] The validation results showed that the RSDs of impurities P, M, A, H, B, C, D, E, Q, F, other individual impurities and the total amount of impurities in the 6 spiked test solutions were 0%, 4.2%, 5.0%, 0%, 0%, 0%, 0%, 5.3%, 0%, 0%, 0%, 0% and 0%, respectively, all less than 6%, indicating that this method has good repeatability.

[0140] 2Intermediate precision

[0141] On different dates, analyst 2 was replaced, and the salbutamol hydrochloride reference solution, test solution, spiked test solution, reference solution ② and spiked test solution ② were prepared in the same way according to the repeatability test operation steps, and the results were determined in the same way on different high performance liquid chromatographs. The content of each impurity was calculated by the external standard method of the main component reference substance with correction factor. The test results were combined with the repeatability test results, and a total of 12 test results were compared to examine the intermediate precision of the method. The test results are shown in Table 9.

[0142] Table 9 Intermediate precision test results

[0143]

[0144] The RSDs of impurities P, M, A, H, B, C, D, E, Q, F, other individual impurities and the total amount of impurities in the 12 spiked test solutions were 2.9%, 4.6%, 5.0%, 1.8%, 0%, 2.8%, 4.8%, 4.2%, 0%, 0%, 0% and 3.8%, respectively, all less than 8%, and the intermediate precision of the method was good.

[0145] 2.6 Accuracy Test

[0146] Mixed stock solution of impurity reference substances①: Take about 2.5 mg of each of impurity A, B, E, M, and P reference substances, place them in the same 20 ml volumetric flask, add solvent to dissolve and dilute to the scale, and shake well.

[0147] Impurity D reference substance stock solution: Take about 2.5 mg of impurity D reference substance, place it in a 20 ml volumetric flask, add solvent to dissolve and dilute to the scale, and shake well.

[0148] Impurity F reference substance stock solution: Take about 2.5 mg of impurity F reference substance, place it in a 20 ml volumetric flask, add solvent to dissolve and dilute to the scale, and shake well.

[0149] Impurity reference substance mixed stock solution ②: Take about 2.5 mg of impurity C reference substance and impurity H reference substance respectively, place them in the same 20 ml volumetric flask, add solvent to dissolve and dilute to the scale, and shake well.

[0150] Impurity reference substance mixed stock solution ③: Accurately measure 4 ml each of impurity reference substance mixed stock solution ①, impurity D reference substance stock solution, impurity reference substance mixed stock solution ②, and 6 ml of impurity F reference substance stock solution, place them in the same 50 ml volumetric flask, dilute to the scale with solvent, and shake well.

[0151] Impurity reference substance mixed stock solution ④: Accurately measure 2 ml of impurity reference substance mixed stock solution ① and impurity F reference substance stock solution, 1 ml of impurity D reference substance stock solution, and 3 ml of impurity reference substance mixed stock solution ②, place them in the same 50 ml volumetric flask, dilute to the scale with solvent, and shake well.

[0152] Impurity reference solution: Accurately measure 2 ml of the impurity reference mixed stock solution ③, place it in a 20 ml volumetric flask, dilute to the scale with solvent, and shake well.

[0153] Test solution: Take about 10 mg of sample, weigh accurately, place in a 20 ml volumetric flask, add solvent to dissolve and dilute to the scale, shake well.

[0154] Low concentration 1 recovery solution: Take about 10 mg of sample, weigh accurately, and accurately measure 1 ml of impurity reference mixed stock solution ④, put it in the same 20 ml volumetric bottle, add solvent to dissolve and dilute to the scale, shake well. Prepare 3 copies in parallel.

[0155] Low concentration 2 recovery rate solution: Take about 10 mg of sample, weigh accurately, and accurately measure 2 ml of impurity reference mixed stock solution ④, put it in the same 20 ml volumetric bottle, add solvent to dissolve and dilute to the scale, shake well. Prepare 3 copies in parallel.

[0156] Medium concentration recovery solution: Take about 10 mg of sample, weigh accurately, and accurately measure 2 ml of impurity reference mixed stock solution ③, put it in the same 20 ml volumetric bottle, add solvent to dissolve and dilute to the scale, shake well. Prepare 3 copies in parallel.

[0157] High concentration recovery solution: Take about 10 mg of sample, weigh accurately, and accurately measure 3 ml of impurity reference mixed stock solution, put it in the same 20 ml volumetric bottle, add solvent to dissolve and dilute to the scale, shake well. Prepare 3 copies in parallel.

[0158] Impurity Q reference substance stock solution: Take about 2 mg of the impurity Q reference substance, accurately weigh it, add acetonitrile to dissolve it and quantitatively dilute it to make a solution containing 2 μg of impurity Q per 1 ml.

[0159] Impurity Q reference solution: Accurately measure 2 ml of the impurity Q reference stock solution, place it in a 20 ml volumetric flask, dilute to the scale with solvent, and shake well.

[0160] Impurity Q low concentration recovery solution: Take about 10 mg of sample, weigh accurately, and place in a 20 ml volumetric flask. Accurately measure 1 ml of impurity Q reference stock solution, place in the same 20 ml volumetric flask, add solvent to dissolve and dilute to scale, shake well. Prepare 3 copies in parallel.

[0161] Impurity Q medium concentration recovery solution: Take about 10 mg of sample, weigh accurately, and place in a 20 ml volumetric flask. Accurately measure 2 ml of impurity Q reference stock solution, place in the same 20 ml volumetric flask, add solvent to dissolve and dilute to scale, shake well. Prepare 3 copies in parallel.

[0162] Impurity Q high concentration recovery solution: Take about 10 mg of sample, weigh accurately, and place in a 20 ml volumetric flask. Accurately measure 3 ml of impurity Q reference stock solution, place in the same 20 ml volumetric flask, add solvent to dissolve and dilute to scale, shake well. Prepare 3 copies in parallel.

[0163] Accurately measure the impurity reference solution, impurity Q reference solution, test solution and each recovery solution, inject them into the high performance liquid chromatograph, record the chromatogram, calculate the detection amount of each impurity by peak area according to the external standard method and calculate the recovery rate. The test results are shown in Table 10.

[0164] Table 10 Accuracy test results

[0165]

[0166]

[0167] The results show that the recovery rates of impurity P, impurity M, impurity A, impurity H, impurity B, impurity C, impurity D, impurity E, impurity Q and impurity F are all in the range of 90% to 108%, indicating that the method has high accuracy.

[0168] 2.7 Durability test

[0169] Replace the chromatographic columns of the same brand, model, specification and different batches, adjust the flow rate, column temperature and the proportion of different mobile phase B, and the test results will not be affected. The durability test results of the influence of different conditions on the determination of impurities P, M, A, H, B, C, D, E, Q, F, other single impurities and the total amount of impurities in the spiked test solution are as follows Figure 2 shown.

[0170] It can be seen that the differences between the contents of various impurities measured after fine-tuning the chromatographic conditions and the results measured under standard conditions are all less than ±20%, indicating that the method has good durability when the column temperature is changed within the range of 30°C to 40°C, the flow rate is 0.8ml / min to 1.2ml / min, and the mobile phase ratio is acetonitrile-methanol-water-phosphoric acid (34:34:32:0.1) to acetonitrile-methanol-water-phosphoric acid (36:36:28:0.1), and when replacing chromatographic columns of the same brand, model, specification, and different batches.

[0171] Comparative Example 1: Detection and separation of impurities under different mobile phase conditions

[0172] Comparative Example 1.1:

[0173] Column: Agilent InfinityLab Poroshell 120EC-C18, 4.6 mm × 250 mm, 4 μm;

[0174] Mobile phase A: 0.1% formic acid solution;

[0175] Mobile phase B: methanol or acetonitrile; gradient elution according to the table below;

[0176]

[0177] The flow rate was 1.0 ml per minute; the column temperature was 35°C; the detection wavelength was 220 nm; the injection volume was 10 μl; the mixed solution of “2.1, specificity test” was injected.

[0178] When mobile phase B is acetonitrile, the chromatogram is as follows Figure 3 As shown in the figure, the baseline noise of this method is too large, there is a bulge in front of the main peak, the gradient peak fluctuates significantly, the response of impurities B, D, and F is very small, and other known impurities are not detected. When mobile phase B is methanol, there is also a bulge in front of the main peak.

[0179] Comparative Example 1.2:

[0180] Chromatographic column: octadecylsilane bonded silica gel as filler (Agilent InfinityLab Poroshell120EC-C18, 4.6 mm × 250 mm, 4 μm);

[0181] Trapping column: Ghost Grasped Column, 4.6mm×50mm;

[0182] Mobile phase A: 0.025 mol / L sodium dihydrogen phosphate buffer (pH adjusted to 3.0 with phosphoric acid)-methanol (88:12);

[0183] Mobile phase B: water-acetonitrile (30:70);

[0184] Other chromatographic conditions were the same as in Example 1.

[0185] Take the mixed solution of "2.1, Specificity Test" and inject it. The result is as follows Figure 4 As shown, the separation between impurity P and the main peak is poor under this method.

[0186] Comparative Example 1.3:

[0187] Mobile phase A: 0.1% phosphoric acid solution;

[0188] Mobile phase B: water-acetonitrile-phosphoric acid (30:70:0.1);

[0189] Trapping column: Ghost Grasped Column, 4.6mm×50mm;

[0190] Other chromatographic conditions were the same as in Example 1.

[0191] Take the mixed solution of "2.1, Specificity Test" and inject it. The result is as follows Figure 5 As shown, the separation between impurity M and the main peak is poor under this method.

[0192] When water-methanol-phosphoric acid (30:70:0.1) was used as mobile phase B, impurity M was completely wrapped by the main peak and showed no signs of separation, and the separation between impurity B and impurity C was poor.

[0193] Comparative Example 1.4:

[0194] Mobile phase A: 0.1% phosphoric acid solution;

[0195] Mobile phase B: water-methanol-acetonitrile-phosphoric acid (30:25:45:0.1);

[0196] Trapping column: Ghost Grasped Column, 4.6mm×50mm;

[0197] Other chromatographic conditions were the same as in Example 1.

[0198] The results are as follows Figure 6 As shown, the salbutamol peak and the impurity M peak did not achieve baseline separation.

[0199] Comparative Example 1.5:

[0200] Mobile phase A: 0.1% phosphoric acid solution;

[0201] Mobile phase B: methanol;

[0202] Trapping column: Ghost Grasped Column, 4.6mm×50mm;

[0203] Other chromatographic conditions were the same as in Example 1.

[0204] The results are as follows Figure 7 As shown, the salbutamol peak and the impurity M peak did not achieve baseline separation, and the separation degree between impurity C and impurity D was poor.

[0205] When mobile phase B was replaced with acetonitrile, the peak of salbutamol and the peak of impurity P showed slight separation, and the peak shape of impurity F was poor.

[0206] Comparative Example 1.6:

[0207] Mobile phase A: 0.1% phosphoric acid solution;

[0208] Mobile phase B: water-methanol-acetonitrile (30:35:35);

[0209] Trapping column: Ghost Grasped Column, 4.6mm×50mm;

[0210] Other chromatographic conditions were the same as in Example 1.

[0211] The results are as follows Figure 8 As shown, the levosalbutamol peak is not baseline separated from the impurity M peak.

[0212] Comparative Example 1.7: No trapping column

[0213] Mobile phase A: 0.1% phosphoric acid solution;

[0214] Mobile phase B: water-methanol-acetonitrile-phosphoric acid (30:35:35:0.1);

[0215] Other chromatographic conditions were the same as in Example 1.

[0216] The results are as follows Fig. 9 As shown, without the trapping column, a cluster of interference peaks appeared in the range of 40min to 46min. In Example 1, after using the trapping column, the baseline was stable in the range of 40min to 46min, each component peak could achieve baseline separation, and each component peak had a good peak shape.

[0217] Comparative Example 2: Detection and separation of impurities under different chromatographic column conditions

[0218] Comparative Example 2.1:

[0219] Chromatographic column: Agilent InfinityLab Poroshell 120SB-C8, 4.6mm×150mm, 2.7μm; mobile phase A is 0.1% phosphoric acid solution, mobile phase B is methanol or acetonitrile, and gradient elution is performed as shown in the following table:

[0220]

[0221] The flow rate was 1.0 ml per minute; the column temperature was 35°C; the detection wavelength was 220 nm; the injection volume was 10 μl; the mixed solution of “2.1, specificity test” was injected.

[0222] When mobile phase B is methanol, the chromatogram is as follows Fig.10 As shown, impurity M, main peak and impurity P are not completely separated. When mobile phase B is acetonitrile, the chromatogram is as follows Fig.11 As shown, the main peak contains impurities P and M. After adjustment, the separation result was not improved.

[0223] Comparative Example 2.2:

[0224] Chromatographic column: Octylsilane bonded silica gel as filler (Kromasil 100-5-C8, 4.6 mm × 250 mm);

[0225] Mobile phase A: 0.1% phosphoric acid solution;

[0226] Mobile phase B: water-methanol-acetonitrile-phosphoric acid (30:35:35:0.1); gradient elution according to the table below;

[0227]

[0228] The flow rate was 1.0 ml per minute; the column temperature was 35°C; the detection wavelength was 220 nm; and the injection volume was 10 μl.

[0229] The results are as follows Fig.12 As shown, impurity B and impurity C cannot be separated, and the gradient peak interferes with the detection of impurity Q.

[0230] Comparative Example 2.3:

[0231] Chromatographic column 2: octadecylsilane bonded silica gel as filler (GL Sciences Inertsil ODS-3, 4.6 mm × 150 mm, 3 μm);

[0232] Other chromatographic conditions were the same as above.

[0233] The results are as follows Fig.13 As shown in the figure, the salbutamol peak cannot be completely separated from the impurity P and impurity M peaks. The results of the impurity separation method of the USP Pharmacopoeia related substances are similar. Fig.13, adjust the mobile phase ratio or gradient to achieve baseline separation.

[0234] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.

Claims

1. An analytical method for detecting impurities including nitrosamines in salbutamol hydrochloride, characterized in that: An octadecylsilane bonded silica gel chromatographic column is used, and the mobile phase includes a mobile phase A and a mobile phase B, wherein the mobile phase A is a phosphoric acid solution, and the mobile phase B is an aqueous solution containing methanol, acetonitrile, and phosphoric acid at the same time; Impurities in salbutamol hydrochloride API include: The nitrosamine impurity is impurity Q in the table; The chromatographic column used was an Agilent InfinityLab Poroshell 120EC-C18 column; the column temperature was 30°C to 40°C; Mobile phase A is a phosphoric acid solution with a mass fraction of 0.05% to 0.15%; The volume ratio of water-methanol-acetonitrile-phosphoric acid in the mobile phase B is 28:36:36:0.1 to 32:34:34:0.1; The mobile phase gradient elution program is as follows: within 0 to 40 minutes, the volume ratio of mobile phase A and mobile phase B changes linearly from 90 to 100:0 to 10 to 70:30; within 40 to 50 minutes, the volume ratio of mobile phase A and mobile phase B changes linearly from 70:30 to 28:72; within 50 to 51 minutes, the volume ratio of mobile phase A and mobile phase B keeps changing linearly from 28:72 to 0:100; within 51 to 56 minutes, the volume ratio of mobile phase A and mobile phase B keeps unchanged at 0:100; within 56 to 57 minutes, the volume ratio of mobile phase A and mobile phase B changes linearly from 0:100 to 90 to 100:0 to 10; within 57 to 70 minutes, the volume ratio of mobile phase A and mobile phase B keeps unchanged at 90 to 100:0 to 10; The flow rate of the mobile phase is 0.8~1.2ml / min.

2. The analytical method for detecting impurities including nitrosamines in salbutamol hydrochloride according to claim 1, characterized in that: Mobile phase A was 0.1% phosphoric acid solution.

3. The analytical method for detecting impurities including nitrosamines in salbutamol hydrochloride according to claim 1, characterized in that: Mobile phase B was 30:35:35:0.

1.

4. The analytical method for detecting impurities including nitrosamines in salbutamol hydrochloride according to claim 1, characterized in that: The mobile phase flow rate was 1.0 ml / min.

5. The analytical method for detecting impurities including nitrosamines in salbutamol hydrochloride according to claim 1, characterized in that: The column temperature was 35°C.

6. The analytical method for detecting impurities including nitrosamines in salbutamol hydrochloride according to claim 1, characterized in that: The analytical method also includes sample preparation: Test solution: Take the sample and dissolve it in solvent to prepare a solution with a concentration of 0.5 mg / ml. The solvent is water; Reference solution: Take the salbutamol hydrochloride reference substance, dissolve it in a solvent and prepare a solution with a concentration of 0.5 μg / ml; Accurately measure the test solution and reference solution, inject them into the liquid chromatograph respectively, and record the chromatogram.

7. The analytical method for detecting impurities including nitrosamines in salbutamol hydrochloride according to claim 1, characterized in that: Detection wavelength: 220nm; Chromatographic column: Agilent InfinityLab Poroshell 120EC-C18 octadecylsilane bonded silica gel column, 4.6 mm × 250 mm, 4 μm; Solvent: water; Mobile phase A: 0.1% phosphoric acid solution; Mobile phase B: water-methanol-acetonitrile-phosphoric acid 30:35:35:0.1; Gradient elution program: within 0-40 minutes, the volume ratio of mobile phase A and mobile phase B linearly changes from 100:0 to 70:30; within 40-50 minutes, the volume ratio of mobile phase A and mobile phase B linearly changes from 70:30 to 28:72; within 50-51 minutes, the volume ratio of mobile phase A and mobile phase B linearly changes from 28:72 to 0:100; within 51-56 minutes, the volume ratio of mobile phase A and mobile phase B remains unchanged at 0:100; within 56-57 minutes, the volume ratio of mobile phase A and mobile phase B linearly changes from 0:100 to 100:0; within 57-70 minutes, the volume ratio of mobile phase A and mobile phase B remains unchanged at 100:0; Flow rate: 1.0 mL / min; Column temperature: 35°C; In the test solution of levosalbutamol hydrochloride, the relative retention times of impurities P, M, A, H, B, C, D, E, Q, and F are 0.97, 1.08, 1.15, 1.24, 1.51, 1.54, 1.66, 1.97, 2.54, and 2.70, respectively.

8. The analytical method for detecting impurities including nitrosamines in salbutamol hydrochloride according to claim 7, characterized in that: The analytical method also includes the calculation of impurity content: If there are impurity peaks in the chromatogram of the test solution, calculate the content of each impurity by the external standard method of the main component reference substance with the correction factor added; The correction factors of impurities P, M, A, H, B, C, D, E, Q, and F are 1.1, 0.7, 1.1, 1.0, 0.8, 0.9, 0.3, 1.0, 0.7, and 0.7, respectively. Among them, impurities P, A, H, C, and E do not need to be corrected.